Sang-ick Chang, MD, MPH

Shreya Jitendra Shah is an esteemed Internal Medicine doctor and Clinical Associate Professor specializing in Primary Care and Population Health. With a robust background in medical informatics and preventive medicine, she is dedicated to improving healthcare outcomes through innovative research and patient engagement strategies. Dr. Shah has held significant administrative roles within Stanford Healthcare, focusing on applied research and the integration of electronic health records to enhance provider efficiency and patient satisfaction. Her extensive publication record highlights her commitment to advancing the field of internal medicine and addressing critical health issues within community health settings. Generated from the website

Radhika Kumari MD is a healthcare facility nestled in the serene town of Portola Valley, CA. With a focus on patient-centered care, this establishment provides a range of medical services designed to cater to diverse healthcare needs. Specializing in various medical disciplines such as preventive medicine, women's health, and chronic disease management, Radhika Kumari MD is committed to offering personalized treatment plans that prioritize patient well-being. Located amidst the picturesque surroundings of Portola Valley, Radhika Kumari MD stands out as a beacon of healthcare excellence in the community. By integrating the latest medical advancements with compassionate care, this facility ensures that patients receive top-notch treatment from a team of dedicated healthcare professionals. Whether seeking routine check-ups or specialized medical interventions, individuals can trust Radhika Kumari MD to deliver quality healthcare services in a welcoming and supportive environment. Generated using this brand's available information

Kavita Sarin, M.D./Ph.D., is an Associate Professor of Dermatology and is the Director of the Stanford Skin Cancer Genetics Program at the Stanford Cancer Institute. She has an academic interest in Precision Medicine, focused on the integration of genetic and clinical patient data to inform susceptibility, prognosis, and treatments in skin cancer and other rare dermatologic disorders.